Hi Aldo, What's New? Advances in Aldosterone in Health and Disease

16 Apr 2024 09:00 am 10:30 am
Hall E
CarlosSchreck Chairperson Hospital Italiano de Buenos Aires- NephrologyArgentina
KellyHaughton Chairperson SLANH, PanamaPanama

Session Description:
This session is designed to provide participants with a review of aldosterone physiology and pathophysiology, an understanding of how to block aldosterone deleterious effects and an introduction to latest therapies in this area.
Learning Objectives:
Identify key elements of aldosterone action in health and disease. Review information on the beneficial effects of aldosterone receptor blockage. Examine critically new aspects of aldosterone synthese blockade.

Time Session
09:00 am
09:18 am
Why Are Fewer Than I% Of Hypertensive Patients Ever Screened For Primary Aldosteronism?
John Funder Speaker John.Funder@hudson.org.auThe Hudson Institute of Medical Research Clayton 3168 Victoria Australia; Monash University, Clayton 3600 Victoria AustraliaAustralia
09:18 am
09:36 am
Aldosterone and Disease
JordanaCohen Speaker jco@pennmedicine.upenn.eduUniversity of PennsylvaniaUnited States
09:36 am
09:54 am
New Trials Using Aldosterone Synthese Blockade
MichelAzizi Speaker michel.azizi@aphp.frUniversité Paris Cité, Hypertension department, HôFrance
09:54 am
10:15 am
Targeting MR for Heart and Kidney Protection
HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands
10:15 am
10:30 am
Q and A